FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912193282> ?p ?o ?g. }

• W2912193282 endingPage "504" @default.
• W2912193282 startingPage "492" @default.
• W2912193282 abstract "Background: Comparative, real-life and long-term evidence on the effectiveness and safety of phototherapy and systemic therapy in moderate-to-severe atopic eczema (AE) is limited. Such data must come from well-designed prospective patient registries. Standardization of data collection is needed for direct comparisons and data pooling. Objectives: To reach a consensus on how and when to measure the previously defined domain items of the TREatment of ATopic eczema (TREAT) Registry Taskforce core dataset for research registries for paediatric and adult patients with AE. Methods: Proposals for the measurement instruments were based on recommendations of the Harmonising Outcome Measures for Eczema (HOME) initiative, the existing AE database of TREATgermany, systematic reviews of the literature and expert opinions. The proposals were discussed at three face-to-face consensus meetings, one teleconference and via e-mail. The frequency of follow-up visits was determined by an expert survey. Results: A total of 16 experts from seven countries participated in the ‘how to measure’ consensus process and 12 external experts were consulted. A consensus was reached for all domain items on how they should be measured by assigning measurement instruments. A minimum follow-up frequency of initially 4 weeks after commencing treatment, then every 3 months while on treatment and every 6 months while off treatment was defined. Conclusions: This core dataset for national AE research registries will aid in the comparability and pooling of data across centres and country borders, and enables international collaboration to assess the long-term effectiveness and safety of phototherapy and systemic therapy used in patients with AE. What's already known about this topic?. Comparable, real-life and long-term data on the effectiveness and safety of phototherapy and systemic therapy in patients with atopic eczema (AE) are needed. There is a high diversity of outcomes and instruments used in AE research, which require harmonization to enhance comparability and allow data pooling. What does this study add?. Our taskforce has reached international consensus on how and when to measure core domain items for national AE research registries. This core dataset is now available for use by researchers worldwide and will aid in the collection of unified data. What are the clinical implications of this work?. The data collected through this core dataset will help to gain better insights into the long-term effectiveness and safety of phototherapy and systemic therapy in AE and will provide important information for clinical practice. Standardization of such data collection at the national level will also allow direct data comparisons and pooling across country borders (e.g. in the analysis of treatment-related adverse events that require large patient numbers)." @default.
• W2912193282 created "2019-02-21" @default.
• W2912193282 creator A5002369909 @default.
• W2912193282 creator A5004775387 @default.
• W2912193282 creator A5005231982 @default.
• W2912193282 creator A5010529831 @default.
• W2912193282 creator A5017819615 @default.
• W2912193282 creator A5020160408 @default.
• W2912193282 creator A5028077261 @default.
• W2912193282 creator A5039777507 @default.
• W2912193282 creator A5042438814 @default.
• W2912193282 creator A5044359700 @default.
• W2912193282 creator A5058073606 @default.
• W2912193282 creator A5068012581 @default.
• W2912193282 creator A5071894286 @default.
• W2912193282 creator A5071907436 @default.
• W2912193282 creator A5072786878 @default.
• W2912193282 creator A5076238160 @default.
• W2912193282 creator A5077872633 @default.
• W2912193282 date "2019-06-23" @default.
• W2912193282 modified "2023-10-12" @default.
• W2912193282 title "<scp>TRE</scp> atment of <scp>AT</scp> opic eczema ( <scp>TREAT</scp> ) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries" @default.
• W2912193282 cites W1967972170 @default.
• W2912193282 cites W1969725546 @default.
• W2912193282 cites W1977571789 @default.
• W2912193282 cites W1979345954 @default.
• W2912193282 cites W1997811303 @default.
• W2912193282 cites W2009746941 @default.
• W2912193282 cites W2019173496 @default.
• W2912193282 cites W2051421086 @default.
• W2912193282 cites W2053248776 @default.
• W2912193282 cites W2076977862 @default.
• W2912193282 cites W2079979502 @default.
• W2912193282 cites W2101568459 @default.
• W2912193282 cites W2102985737 @default.
• W2912193282 cites W2192134383 @default.
• W2912193282 cites W2305795634 @default.
• W2912193282 cites W2337558094 @default.
• W2912193282 cites W2419580390 @default.
• W2912193282 cites W2487179012 @default.
• W2912193282 cites W2518331667 @default.
• W2912193282 cites W2520198258 @default.
• W2912193282 cites W2555680885 @default.
• W2912193282 cites W2557191479 @default.
• W2912193282 cites W2585119260 @default.
• W2912193282 cites W2593383097 @default.
• W2912193282 cites W2620177205 @default.
• W2912193282 cites W2751457797 @default.
• W2912193282 cites W2802952796 @default.
• W2912193282 cites W2804940047 @default.
• W2912193282 cites W2893944246 @default.
• W2912193282 cites W3190527361 @default.
• W2912193282 doi "https://doi.org/10.1111/bjd.17715" @default.
• W2912193282 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6771812" @default.
• W2912193282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30719709" @default.
• W2912193282 hasPublicationYear "2019" @default.
• W2912193282 type Work @default.
• W2912193282 sameAs 2912193282 @default.
• W2912193282 citedByCount "25" @default.
• W2912193282 countsByYear W29121932822019 @default.
• W2912193282 countsByYear W29121932822020 @default.
• W2912193282 countsByYear W29121932822021 @default.
• W2912193282 countsByYear W29121932822022 @default.
• W2912193282 countsByYear W29121932822023 @default.
• W2912193282 crossrefType "journal-article" @default.
• W2912193282 hasAuthorship W2912193282A5002369909 @default.
• W2912193282 hasAuthorship W2912193282A5004775387 @default.
• W2912193282 hasAuthorship W2912193282A5005231982 @default.
• W2912193282 hasAuthorship W2912193282A5010529831 @default.
• W2912193282 hasAuthorship W2912193282A5017819615 @default.
• W2912193282 hasAuthorship W2912193282A5020160408 @default.
• W2912193282 hasAuthorship W2912193282A5028077261 @default.
• W2912193282 hasAuthorship W2912193282A5039777507 @default.
• W2912193282 hasAuthorship W2912193282A5042438814 @default.
• W2912193282 hasAuthorship W2912193282A5044359700 @default.
• W2912193282 hasAuthorship W2912193282A5058073606 @default.
• W2912193282 hasAuthorship W2912193282A5068012581 @default.
• W2912193282 hasAuthorship W2912193282A5071894286 @default.
• W2912193282 hasAuthorship W2912193282A5071907436 @default.
• W2912193282 hasAuthorship W2912193282A5072786878 @default.
• W2912193282 hasAuthorship W2912193282A5076238160 @default.
• W2912193282 hasAuthorship W2912193282A5077872633 @default.
• W2912193282 hasBestOaLocation W29121932821 @default.
• W2912193282 hasConcept C2780009758 @default.
• W2912193282 hasConcept C41008148 @default.
• W2912193282 hasConcept C71924100 @default.
• W2912193282 hasConcept C77088390 @default.
• W2912193282 hasConceptScore W2912193282C2780009758 @default.
• W2912193282 hasConceptScore W2912193282C41008148 @default.
• W2912193282 hasConceptScore W2912193282C71924100 @default.
• W2912193282 hasConceptScore W2912193282C77088390 @default.
• W2912193282 hasFunder F4320309229 @default.
• W2912193282 hasIssue "3" @default.
• W2912193282 hasLocation W29121932821 @default.
• W2912193282 hasLocation W29121932822 @default.
• W2912193282 hasLocation W29121932823 @default.
• W2912193282 hasLocation W29121932824 @default.
• W2912193282 hasLocation W29121932825 @default.

• next